National Institutes of Healths National Library of Medicine) there are over 500 peer-refereed publications involving various aspects of creatine supplementation as of 2021 (Ref.2)
86 Izquierdo-Casas, J
Publications and citations The latest in science and research Breakthrough ELISA & CLIA Kits from Innovative Research By Adam Awdish On Aug 16, 2024 At Innovative Research, we're committed to providing cutting-edge tools that empower your scientific discoveries
Individual responses vary, and anyone considering peptide research should do thorough due diligence
Researchers concluded that a subgroup of [Alzheimers] patients aged 65 or younger may benefit from treatment with [ALCAR] whereas older individuals might do more poorly. 13 A follow up study reanalyzed the results and came to similar conclusions, suggesting that ALCAR slows the progression of Alzheimers disease in younger subjects. 14 In another follow-up study that compared ALCARs effect on those with early-onset (age 45-65) and regular Alzheimers, researchers reached a different conclusion, reporting that there were no significant differences between the treatment groups. 15 ALCAR 1,500 mg seems to help with depression in the elderly In this study, 28 elderly patients aged 70-80 who had been diagnosed with depression were given either 1,500 mg Acetyl-L-Carnitine or placebo daily, and were then evaluated with three cognitive tests and by clinical observation
Int J Health Policy Manag
